☰

Martin M. Dcona - Publications

Affiliations: 
Virginia Commonwealth University School of Medicine, Richmond, VA 
Area:
Chemistry and Drug Discovery
Tree Info Similar researchers PubMed Report error

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Chougoni KK, Park H, Damle PK, Mason T, Cheng B, Dcona MM, Szomju B, Dozmorov MG, Idowu MO, Grossman SR. Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma. Oncogenesis. 12: 53. PMID 37949862 DOI: 10.1038/s41389-023-00498-8  0.565
2019 Dcona MM, Damle PK, Zarate-Perez F, Morris BL, Nawaz Z, Dennis MJ, Deng X, Korwar S, Singh S, Ellis KC, Royer WE, Bandyopadhyay D, Escalante C, Grossman SR. Active-site tryptophan, the target of anti-neoplastic CtBP inhibitors, mediates inhibitor disruption of CtBP oligomerization and transcription coregulatory activities. Molecular Pharmacology. PMID 31036695 DOI: 10.1124/Mol.118.114363  0.615
2019 Royer WE, Bellesis AG, Jecrois AM, Hilbert BJ, Dcona MM, Grossman SR, Schiffer CA. Tetrameric Assembly of the Oncogenic C-Terminal Binding Proteins Biophysical Journal. 116: 62a. DOI: 10.1016/J.Bpj.2018.11.380  0.547
2017 Dcona MM, Morris BL, Ellis KC, Grossman SR. CtBP- an emerging oncogene and novel small molecule drug target: advances in the understanding of its oncogenic action and identification of therapeutic inhibitors. Cancer Biology & Therapy. 0. PMID 28532298 DOI: 10.1080/15384047.2017.1323586  0.619
2017 Dcona MM, Morris BL, Damle PK, Nawaz Z, Perez FZ, Dennis MJ, Singh SJ, Royer WE, Ellis KC, Grossman SR. Abstract 3204: Tryptophan 318/324, the target of C-terminal binding protein (CtBP) inhibitors, plays a critical role in CtBP enzymatic activity, oligomerization and transcriptional coregulation Cancer Research. 77: 3204-3204. DOI: 10.1158/1538-7445.Am2017-3204  0.581
2016 Dcona MM, Sheldon JE, Mitra D, Hartman MC. Light induced drug release from a folic acid-drug conjugate. Bioorganic & Medicinal Chemistry Letters. PMID 28040391 DOI: 10.1016/J.Bmcl.2016.12.036  0.622
2016 Sumner ET, Korwar S, Morris BL, Dcona MM, Hilbert BJ, Royer WE, Ellis KC, Grossman S. Abstract 2003: C-terminal binding protein (CtBP): An emerging oncogene and small molecule drug target in solid tumors Cancer Research. 76: 2003-2003. DOI: 10.1158/1538-7445.Am2016-2003  0.617
2015 Sheldon JE, Dcona MM, Lyons CE, Hackett JC, Hartman MC. Photoswitchable anticancer activity via trans-cis isomerization of a combretastatin A-4 analog. Organic & Biomolecular Chemistry. PMID 26503632 DOI: 10.1039/C5Ob02005K  0.571
2013 Dcona MM, Mitra D, Goehe RW, Gewirtz DA, Lebman DA, Hartman MCT. Abstract 5665: New alternatives to photodynamic therapy based on light-enabled drug delivery. Cancer Research. 73: 5665-5665. DOI: 10.1158/1538-7445.Am2013-5665  0.432
2013 Mitra D, Dcona MM, Hartman MCT. Abstract 4506: Photocaged molecules in targeted drug delivery. Cancer Research. 73: 4506-4506. DOI: 10.1158/1538-7445.Am2013-4506  0.471
2012 Hartman MC, Dcona MM. A new, highly water-soluble, fluorescent turn-on chemodosimeter for direct measurement of hydrogen sulfide in biological fluids. The Analyst. 137: 4910-2. PMID 22962656 DOI: 10.1039/C2An35870K  0.556
2012 Dcona MM, Mitra D, Goehe RW, Gewirtz DA, Lebman DA, Hartman MC. Photocaged permeability: a new strategy for controlled drug release. Chemical Communications (Cambridge, England). 48: 4755-7. PMID 22473358 DOI: 10.1039/C2Cc30819C  0.622
Show low-probability matches.